Michael J Sorich

Summary

Affiliation: University of South Australia
Country: Australia

Publications

  1. ncbi Recent advances in the in silico modelling of UDP glucuronosyltransferase substrates
    Michael J Sorich
    Sansom Institute, University of South Australia, Adelaide, SA 5000, Australia
    Curr Drug Metab 9:60-9. 2008
  2. ncbi Rapid prediction of chemical metabolism by human UDP-glucuronosyltransferase isoforms using quantum chemical descriptors derived with the electronegativity equalization method
    Michael J Sorich
    School of Pharmacy and Medical Sciences, University of South Australia, Frome Road, Adelaide, SA 5000, Australia
    J Med Chem 47:5311-7. 2004
  3. ncbi Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data
    M J Sorich
    School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia
    J Thromb Haemost 8:1678-84. 2010
  4. ncbi The importance of local chemical structure for chemical metabolism by human uridine 5'-diphosphate-glucuronosyltransferase
    Michael J Sorich
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Frome Rd, Adelaide, SA 5000, Australia
    J Chem Inf Model 46:2692-7. 2006
  5. ncbi Comparison of linear and nonlinear classification algorithms for the prediction of drug and chemical metabolism by human UDP-glucuronosyltransferase isoforms
    Michael J Sorich
    University of South Australia, Adelaide, South Australia, Australia
    J Chem Inf Comput Sci 43:2019-24. 2003
  6. ncbi Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?
    Lv Wang
    Sansom Institute, University of South Australia, Adelaide, South Australia, Australia
    Autism Res 3:268-72. 2010
  7. ncbi Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivity
    Michael J Sorich
    School of Pharmaceutical, Molecular and Biomedical Sciences, University of South Australia, Adelaide, Australia
    Mol Pharmacol 65:301-8. 2004
  8. ncbi Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches
    John O Miners
    Department of Clinical Pharmacology, Flinders University and Flinders Medical Center, Bedford Park, Adelaide, SA 5042, Australia
    Annu Rev Pharmacol Toxicol 44:1-25. 2004
  9. ncbi A review of candidate urinary biomarkers for autism spectrum disorder
    Lv Wang
    Sansom Institute for Health Research, University of South Australia, Adelaide
    Biomarkers 16:537-52. 2011
  10. ncbi Effect of steric molecular field settings on CoMFA predictivity
    Ruchi R Mittal
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA 5000, Australia
    J Mol Model 14:59-67. 2008

Collaborators

Detail Information

Publications20

  1. ncbi Recent advances in the in silico modelling of UDP glucuronosyltransferase substrates
    Michael J Sorich
    Sansom Institute, University of South Australia, Adelaide, SA 5000, Australia
    Curr Drug Metab 9:60-9. 2008
    ..Furthermore, improved protein structure data on UGTs will enable the application of structural modelling techniques likely leading to greater insight into the binding and reactive processes of UGT catalysed glucuronidation...
  2. ncbi Rapid prediction of chemical metabolism by human UDP-glucuronosyltransferase isoforms using quantum chemical descriptors derived with the electronegativity equalization method
    Michael J Sorich
    School of Pharmacy and Medical Sciences, University of South Australia, Frome Road, Adelaide, SA 5000, Australia
    J Med Chem 47:5311-7. 2004
    ..It is likely that EEM-derived QC properties will be generally useful for predicting ADMET and physicochemical properties during drug discovery...
  3. ncbi Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data
    M J Sorich
    School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia
    J Thromb Haemost 8:1678-84. 2010
    ..Whether the CYP2C19 genotype has the potential to influence clinical choice of these drugs prior to PCI for individuals with unstable angina or non-ST segment elevation myocardial infarction is currently uncertain...
  4. ncbi The importance of local chemical structure for chemical metabolism by human uridine 5'-diphosphate-glucuronosyltransferase
    Michael J Sorich
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Frome Rd, Adelaide, SA 5000, Australia
    J Chem Inf Model 46:2692-7. 2006
    ....
  5. ncbi Comparison of linear and nonlinear classification algorithms for the prediction of drug and chemical metabolism by human UDP-glucuronosyltransferase isoforms
    Michael J Sorich
    University of South Australia, Adelaide, South Australia, Australia
    J Chem Inf Comput Sci 43:2019-24. 2003
    ....
  6. ncbi Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?
    Lv Wang
    Sansom Institute, University of South Australia, Adelaide, South Australia, Australia
    Autism Res 3:268-72. 2010
    ..In conclusion, routine screening for abnormal urinary CR and GAA could be considered in ASD diagnostic protocols; however, individuals positive for CDS are likely to be rare in an ASD cohort...
  7. ncbi Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivity
    Michael J Sorich
    School of Pharmaceutical, Molecular and Biomedical Sciences, University of South Australia, Adelaide, Australia
    Mol Pharmacol 65:301-8. 2004
    ..The pharmacophores further suggest that the environment immediately adjacent to the nucleophilic site of conjugation is an important determinant of metabolism by a particular UGT...
  8. ncbi Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches
    John O Miners
    Department of Clinical Pharmacology, Flinders University and Flinders Medical Center, Bedford Park, Adelaide, SA 5042, Australia
    Annu Rev Pharmacol Toxicol 44:1-25. 2004
    ..This review assesses the utility of in vitro and in silico approaches for the qualitative and quantitative prediction of drug glucuronidation parameters and the challenges facing the development of generalizable models...
  9. ncbi A review of candidate urinary biomarkers for autism spectrum disorder
    Lv Wang
    Sansom Institute for Health Research, University of South Australia, Adelaide
    Biomarkers 16:537-52. 2011
    ..There are no reliable laboratory tests available to confirm an autism diagnosis...
  10. ncbi Effect of steric molecular field settings on CoMFA predictivity
    Ruchi R Mittal
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA 5000, Australia
    J Mol Model 14:59-67. 2008
    ..Furthermore, depending on the steric field type used, the field sampling density (i.e. grid spacing) has a variable influence on the predictive ability of the models generated...
  11. ncbi Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substrates
    Michael J Sorich
    School of Pharmaceutical, Molecular and Biomedical Sciences, University of South Australia, South Australia, Australia
    Pharmacogenetics 12:635-45. 2002
    ....
  12. ncbi Molecular modeling approaches for the prediction of the nonspecific binding of drugs to hepatic microsomes
    Matthew J Sykes
    Department of Clinical Pharmacology, Flinders University and Flinders Medical Centre, Adelaide, Australia
    J Chem Inf Model 46:2661-73. 2006
    ..Additionally, computationally generated values of log P were shown to provide a reasonable estimate of the fraction unbound in microsomes, providing the compounds were in their basic form at physiological pH...
  13. ncbi Partial charge calculation method affects CoMFA QSAR prediction accuracy
    Ruchi R Mittal
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA 5000, Australia
    J Chem Inf Model 49:704-9. 2009
    ....
  14. ncbi Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism
    Lv Wang
    Sansom Institute for Health Research, University of South Australia, Adelaide, South Australia, Australia
    Appl Environ Microbiol 77:6718-21. 2011
    ..Lower relative abundances of Bifidobacteria species and the mucolytic bacterium Akkermansia muciniphila were found in children with autism, the latter suggesting mucus barrier changes...
  15. ncbi Comparison data sets for benchmarking QSAR methodologies in lead optimization
    Ruchi R Mittal
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia 5000, Australia
    J Chem Inf Model 49:1810-20. 2009
    ..Use of this benchmark set will be useful for both assessment of new methods and for optimization of existing methods...
  16. ncbi Systematic statistical comparison of comparative molecular similarity indices analysis molecular fields for computer-aided lead optimization
    Mafalda M Dias
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Austalia, Adelaide SA 5000, Australia
    J Chem Inf Model 46:2015-21. 2006
    ..Data sets were clustered into four groups on the basis of the utility of molecular field sets to generate predictive models...
  17. ncbi Pharmacists' role in targeted cancer therapy in Australia and implications for pharmacy education
    David M Plevin
    University of South Australia, Adelaide, Australia
    Am J Pharm Educ 74:168. 2010
    ..To investigate the pharmacists' role in providing targeted therapies to patients and its implications for pharmacy education...
  18. ncbi A critical analysis of barriers to the clinical implementation of pharmacogenomics
    Ross A McKinnon
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia Adelaide, SA, Australia
    Ther Clin Risk Manag 3:751-9. 2007
    ..Although long overdue, many of these potential barriers are now being subjected to closer examination and as a result, a framework for successful clinical uptake of pharmacogenomics is emerging...
  19. ncbi Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?
    Lv Wang
    Sansom Institute, University of South Australia, South Australia, Australia
    Biomarkers 14:596-603. 2009
    ..Urinary IAG, however, was not statistically significantly higher in children with ASD, compared with siblings or unrelated controls without ASD...
  20. ncbi Pharmacophore and quantitative structure-activity relationship modeling: complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 substrate selectivity
    Paul A Smith
    Department of Clinical Pharmacology, Flinders University, Bedford Park, 5042, South Australia
    J Med Chem 46:1617-26. 2003
    ..Both UGT1A4 pharmacophores included two hydrophobic features and the glucuronidation site. The 2D-QSAR showed the best overall predictivity and highlighted the importance of hydrophobicity (as log P) in substrate-enzyme binding...